Business Wire - OptiNose Files Investigational New Drug Application to use Sumatriptan Delivered with its Novel Drug Delivery Technology
Posted by admin / Under Migraine Headache
February 2, 2012 --
YARDLEY, Pa. -- OptiNose Inc. announces the filing of an Investigational New Drug (IND) with the U.S. Food and Drug Administration...
Published on Tuesday 21st of February 2012 10:21:26 PM
Share this!